Drug Shortage Report for DILANTIN
Report ID | 176202 |
Drug Identification Number | 00022772 |
Brand name | DILANTIN |
Common or Proper name | DILANTIN |
Company Name | BGP PHARMA ULC |
Market Status | MARKETED |
Active Ingredient(s) | PHENYTOIN SODIUM |
Strength(s) | 30MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | N03AB |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2023-01-16 |
Actual start date | |
Estimated end date | 2023-03-14 |
Actual end date | 2023-03-07 |
Shortage status | Resolved |
Updated date | 2023-03-20 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2023-03-20 | French | Compare |
v7 | 2023-03-20 | English | Compare |
v6 | 2023-02-14 | French | Compare |
v5 | 2023-02-14 | English | Compare |
v4 | 2023-01-17 | French | Compare |
v3 | 2023-01-17 | English | Compare |
v2 | 2022-11-29 | French | Compare |
v1 | 2022-11-29 | English | Compare |
Showing 1 to 8 of 8